[go: up one dir, main page]

FI931576L - Oralt givet loesningsfritt farmaceutiskt preparat med foerdroejd frigoerning av verkande aemne och foerfarande foer framstaellning av preparatet - Google Patents

Oralt givet loesningsfritt farmaceutiskt preparat med foerdroejd frigoerning av verkande aemne och foerfarande foer framstaellning av preparatet Download PDF

Info

Publication number
FI931576L
FI931576L FI931576A FI931576A FI931576L FI 931576 L FI931576 L FI 931576L FI 931576 A FI931576 A FI 931576A FI 931576 A FI931576 A FI 931576A FI 931576 L FI931576 L FI 931576L
Authority
FI
Finland
Prior art keywords
preparatet
loesningsfritt
frigoerning
foerdroejd
verkande
Prior art date
Application number
FI931576A
Other languages
English (en)
Other versions
FI931576A0 (fi
FI108401B (fi
Inventor
Ulrich Muench
Hans-Juergen Mika
Bernhard Emschermann
Rainer Schmidt
Bernhard Sczepanik
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6415859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI931576(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of FI931576A0 publication Critical patent/FI931576A0/fi
Publication of FI931576L publication Critical patent/FI931576L/fi
Application granted granted Critical
Publication of FI108401B publication Critical patent/FI108401B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI931576A 1990-10-08 1993-04-07 Menetelmõ suun kautta annettavan, liuotinta sisõltõmõtt÷mõn, vaikuttavaa ainetta viivytetysti vapauttavan farmaseuttisen valmisteen valmistamiseksi FI108401B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4031881A DE4031881C2 (de) 1990-10-08 1990-10-08 Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
DE4031881 1990-10-08
PCT/DE1991/000791 WO1992005774A1 (de) 1990-10-08 1991-10-07 Lösungsmittelfreie, oral zu verabreichende pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung und verfahren zu deren herstellung
DE9100791 1991-10-07

Publications (3)

Publication Number Publication Date
FI931576A0 FI931576A0 (fi) 1993-04-07
FI931576L true FI931576L (fi) 1993-04-07
FI108401B FI108401B (fi) 2002-01-31

Family

ID=6415859

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931576A FI108401B (fi) 1990-10-08 1993-04-07 Menetelmõ suun kautta annettavan, liuotinta sisõltõmõtt÷mõn, vaikuttavaa ainetta viivytetysti vapauttavan farmaseuttisen valmisteen valmistamiseksi

Country Status (24)

Country Link
US (1) US5453283A (fi)
EP (1) EP0552227B2 (fi)
JP (1) JP3233929B2 (fi)
KR (1) KR0166599B1 (fi)
AT (1) ATE116843T1 (fi)
CA (1) CA2093666C (fi)
CZ (1) CZ284923B6 (fi)
DE (2) DE4031881C2 (fi)
DK (1) DK0552227T4 (fi)
ES (1) ES2067250T5 (fi)
FI (1) FI108401B (fi)
GR (1) GR3015131T3 (fi)
HR (1) HRP920960B1 (fi)
HU (2) HUT64211A (fi)
IE (1) IE76142B1 (fi)
LV (1) LV11002B (fi)
PL (1) PL167593B1 (fi)
PT (1) PT99168B (fi)
RU (1) RU2101009C1 (fi)
SI (1) SI9111618B (fi)
SK (1) SK279446B6 (fi)
UA (1) UA26449C2 (fi)
WO (1) WO1992005774A1 (fi)
YU (1) YU48766B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3459421B2 (ja) * 1992-12-23 2003-10-20 サイテック ソチエタ レスポンサビリタ リミテ 調節された開放医薬形の調製法及びそのようにして得られた医薬形
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
WO1996031197A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
HRP970485A2 (en) 1996-09-13 1998-08-31 Joerg Rosenberg Process for producing solid pharmaceutical forms
US5851555A (en) * 1997-08-15 1998-12-22 Fuisz Technologies Ltd. Controlled release dosage forms containing water soluble drugs
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10029201A1 (de) 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
EP1337283A4 (en) * 2000-10-27 2005-05-18 Nitromed Inc METHODS OF TREATING VASCULAR DISEASES CHARACTERIZED BY NITROGEN MONOXIDE INSUFFICIENCY
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
RU2267318C1 (ru) * 2004-05-25 2006-01-10 Закрытое акционерное общество "ФАРМАПЭК" Пролонгированный антиангинальный препарат изосорбида динитрата и способ его получения
MY148074A (en) * 2005-05-10 2013-02-28 Novartis Ag Pharmaceutical compositions comprising imatinib and a release retardant
RU2408368C2 (ru) 2005-06-27 2011-01-10 Биовэйл Лэборэториз Интернэшнл С.Р.Л. Препараты соли бупропиона с модифицированным высвобождением
US20090246276A1 (en) 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
KR101659983B1 (ko) * 2012-12-31 2016-09-26 주식회사 삼양바이오팜 용융 압출된 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제
WO2017086835A1 (ru) * 2015-11-17 2017-05-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты)
WO2019087084A1 (en) 2017-11-02 2019-05-09 Eman Biodiscoveries Sd. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297357A (fi) * 1962-08-31
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
ZA723701B (en) * 1971-06-04 1973-04-25 Boehringer Mannheim Gmbh Process for the granulation of powdered tablet masses
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US5246714A (en) * 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3612211A1 (de) * 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
DE3743947A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur gesteuerten abgabe von nicotin, verfahren zu ihrer herstellung sowie ihre verwendung
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung
DE3812567A1 (de) * 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline

Also Published As

Publication number Publication date
DK0552227T3 (da) 1995-03-27
IE913592A1 (en) 1992-04-08
DE4031881A1 (de) 1992-04-09
HUT64211A (en) 1993-12-28
FI931576A0 (fi) 1993-04-07
WO1992005774A1 (de) 1992-04-16
LV11002B (en) 1996-06-20
PT99168B (pt) 1999-04-30
DE59104271D1 (de) 1995-02-23
PT99168A (pt) 1992-09-30
CZ284923B6 (cs) 1999-04-14
FI108401B (fi) 2002-01-31
YU48766B (sh) 1999-12-27
SI9111618A (en) 1997-12-31
YU161891A (sh) 1994-06-10
LV11002A (lv) 1996-02-20
ES2067250T5 (es) 1999-02-01
SK279446B6 (sk) 1998-11-04
UA26449C2 (uk) 1999-08-30
DE4031881C2 (de) 1994-02-24
EP0552227A1 (de) 1993-07-28
DK0552227T4 (da) 1999-07-19
SI9111618B (sl) 1999-08-31
EP0552227B1 (de) 1995-01-11
CA2093666C (en) 1998-05-19
US5453283A (en) 1995-09-26
CA2093666A1 (en) 1992-04-09
CS305091A3 (en) 1992-04-15
HU9300995D0 (en) 1993-07-28
KR930701963A (ko) 1993-09-08
ES2067250T3 (es) 1995-03-16
IE76142B1 (en) 1997-10-08
RU2101009C1 (ru) 1998-01-10
KR0166599B1 (ko) 1999-01-15
JP3233929B2 (ja) 2001-12-04
GR3015131T3 (en) 1995-05-31
PL167593B1 (pl) 1995-09-30
HU211845A9 (en) 1995-12-28
EP0552227B2 (de) 1998-11-04
JPH06501685A (ja) 1994-02-24
ATE116843T1 (de) 1995-01-15
HRP920960B1 (en) 1998-10-31
HRP920960A2 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
FI931576L (fi) Oralt givet loesningsfritt farmaceutiskt preparat med foerdroejd frigoerning av verkande aemne och foerfarande foer framstaellning av preparatet
FI921946L (fi) Anvaendning av hydrokolloider foer formulering och framstaellning av soetsaksprodukter med laog fetthalt och laog vattenaktivitet och framstaellningsprocess
FI932809A0 (fi) Kaernreaktoranlaeggning med en kaernspaerranordning och foerfarande foer avkylning av densamma i naturligt kretslopp
FI923677A7 (fi) Foerfarande och anordning foer entydig kombinering av foer en bestaemd behandling avsedda laekemedel med en bestaemd patient
FI925498L (fi) Foerfarande foer framstaellning av modifierat fibermaterial och foerfarande foer faergning av modifierat fibermaterial med anioniska textilfaerger
FI924382A7 (fi) Foerfarande och anordning foer jontoforetisk avgivning av laekemedel
FI924472L (fi) Foerfarande och komposition foer behandling av trombos
FI931987L (fi) Baerfodral av korgtyp foersett med handtag och foerdelningsceller
FI925480A0 (fi) Vattenloeslig pentacyklisk triterpenkomposition och foerfarande foer framstaellning av densamma
FI924272A7 (fi) Foerfarande och anordning foer maskinbearbetning av valsar och liknande arbetsstycken
FI923747L (fi) Kompositioner och foerfaranden foer behandling av infektioner foerorsakade av organismer sensitiva foer b-laktamantibiotika
FI925916L (fi) Foerfarande och dispergeringsmedel foer framstaellning av vattenhaltiga kalciumkarbonatsuspensioner med hoeg torrsubstanshalt
FI930905L (fi) Foerfarande foer uppsamling och behandling av icke-vattenhaltiga droppvaetskor
FI925052L (fi) Foerfarande foer kontinuerlig framstaellning av sanitetsprodukter saosom bloejbyxor och saolunda framstaelld sanitetsprodukt
FI923814L (fi) Foerfarande foer oevervakning och reglering av primaer kaernbildning av jaernsmaeltor
FI921689L (fi) Oligosackarid med affinitet foer fibroblasttillvaextfaktor och foerfarande foer framstaellning av denna
FI922877L (fi) Kristallina olefinpolymerer och sampolymerer i form av sfaeriska partiklar med hoeg porositet
FI924779L (fi) N-fenyl-2-cyano-3-hydroxikrotonsyraamidderivat och anvaendning av dessasom laekemedel med en immunomodulerande egenskap
FI930860L (fi) Tropolonderivat och farmaceutiska kompositioner saerav foer avvaerjning och behandling av iskemiska sjukdomar
FI924713L (fi) Foerfarande foer saollning av proteinpartner och anvaendning av dessa
FI925692A7 (fi) Foerfarande och anordning foer testning och oevervakning av majoritetsroestning
FI925453L (fi) Lipasderivat stimulerade av maenniskans gallsalter och farmaceutiska aemnen innehaollande daerav
FI924094L (fi) Foerfarande foer framstaellning av skyddsgas och gasblandning foer detta
FI924549A0 (fi) Tvaettkomposition och testanordning och -metod foer bestaemning av mikroorganismer foerknipade med tandsjukdomar
FI933198A0 (fi) Flytbaeddsbraennkammare med anordningar foer foerbaettring av foerdelning avbraensle och gaser

Legal Events

Date Code Title Description
MA Patent expired